Mass General Brigham is announcing the spinout of AIwithCare, a company founded by researchers from the health system who developed an artificial intelligence (AI) screening tool that significantly ...

Psyence Biomedical Ltd. has announced significant progress in its Phase IIb clinical trial investigating nature-derived psilocybin combined with psychotherapy as a treatment for Adjustment Disorder in ...

A new study in the journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates.

Early cancer screening can play a transformative role in healthcare, potentially saving lives by identifying cancer before it progresses to an advanced, less treatable stage. However, designing ...

HealthDay News — Compared with manual screening, an artificial intelligence (AI)-assisted patient screening tool can improve the rate of eligibility determination and enrollment for randomized ...

Efren Flores, MD, of Harvard Medical School and Massachusetts General Hospital, discussed the findings of a subanalysis of the Screen ASSIST tobacco cessation clinical trial. Several sociodemographic ...

Artificial intelligence (AI) can rapidly screen patients for clinical trial enrollment, according to a new study published in JAMA and led by Mass General Brigham researchers. Their novel AI-assisted ...

Researchers at Mass General Brigham found that artificial intelligence software like ChatGPT could help speed up the screening process to find patients eligible for clinical trials—though they ...

GPT-4 outperforms GPT-3.5 in clinical trial patient screening but is slower and more expensive, requiring human oversight due to potential errors. Low patient accrual in clinical trials is a major ...

Please provide your email address to receive an email when new articles are posted on . The most missed recommendation was trial registrations (0%), followed by informed consent materials (20%). More ...

A phase 3 global trial is enrolling previously treated locally advanced/metastatic nonsquamous NSCLC to define DATROWAY efficacy and safety at scale. IDE034 is in open-label phase 1 ...

Implementing AI-assisted screening tool enhances clinical trial efficiency, expedites screening process. (HealthDay News) — Compared with manual screening, an artificial intelligence (AI)-assisted ...